Global X MSCI Nigeria ETF (NGE) Chart & Stock Price History → Tech GIANT’s Plans to Revolutionize Crypto… (From Crypto 101 Media) (Ad) Free NGE Stock Alerts $3.74 0.00 (0.00%) (As of 03/25/2024) Add Compare Share Share ChartStock AnalysisChartHoldingsOwnershipStock AnalysisChartHoldingsOwnership Global X MSCI Nigeria ETF Stock Price Performance5 Day Performance0.00%1 Month Performance0.00%3 Month Performance+1.63%6 Month Performance-53.25%Year-To-Date Performance-31.50%1 Year Performance-60.71% Receive NGE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Global X MSCI Nigeria ETF and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsCould this Tiny Biotech End Disease Forever?Imagine a revolutionary treatment capable of editing out ANY disease. By literally "cutting" the genetic instructions that cause illness, and "pasting" in corrected DNA to restore perfect health.Access my full "Cut & Paste" profit analysis now. NGE Stock Chart for Wednesday, May, 8, 2024 NGE Chart by TradingView Global X MSCI Nigeria ETF Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/07/2024$3.74$3.74$3.74$3.7218,200 shs$11.07 million05/06/2024$3.74$3.74$3.74$3.7218,200 shs$11.07 million05/03/2024$3.74$3.74$3.74$3.7218,200 shs$11.07 million05/02/2024$3.74$3.74$3.74$3.7218,200 shs$11.07 million05/01/2024$3.74$3.74$3.74$3.7218,200 shs$11.07 million04/30/2024$3.74$3.74$3.74$3.7218,200 shs$11.07 million Get the Latest News and Ratings for NGE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Global X MSCI Nigeria ETF and its competitors with MarketBeat's FREE daily newsletter. 04/29/2024$3.74$3.74$3.74$3.7218,200 shs$11.07 million04/26/2024$3.74$3.74$3.74$3.7218,200 shs$11.07 million04/25/2024$3.74$3.74$3.74$3.7218,200 shs$11.07 million04/24/2024$3.74$3.74$3.74$3.7218,200 shs$11.07 million04/23/2024$3.74$3.74$3.74$3.7218,200 shs$11.07 million04/22/2024$3.74$3.74$3.74$3.7218,200 shs$11.07 million04/19/2024$3.74$3.74$3.74$3.7218,200 shs$11.07 million04/18/2024$3.74$3.74$3.74$3.7218,200 shs$11.07 million04/17/2024$3.74$3.74$3.74$3.7218,200 shs$11.07 million04/16/2024$3.74$3.74$3.74$3.7218,200 shs$11.07 million04/15/2024$3.74$3.74$3.74$3.7218,200 shs$11.07 million04/12/2024$3.74$3.74$3.74$3.7218,200 shs$11.07 million04/11/2024$3.74$3.74$3.74$3.7218,200 shs$11.07 million04/10/2024$3.74$3.74$3.74$3.7218,200 shs$11.07 million04/09/2024$3.74$3.74$3.74$3.7218,200 shs$11.07 million04/08/2024$3.74$3.74$3.74$3.7218,200 shs$11.07 million04/05/2024$3.74$3.74$3.74$3.7218,200 shs$11.07 million04/04/2024$3.74$3.74$3.74$3.7218,200 shs$11.07 million04/03/2024$3.74$3.74$3.74$3.7218,200 shs$11.07 million04/02/2024$3.74$3.74$3.74$3.7218,200 shs$11.07 million04/01/2024$3.74$3.74$3.74$3.7218,200 shs$11.07 million03/29/2024$3.74$3.74$3.74$3.7218,296 shs$11.07 million03/28/2024$3.74$3.74$3.74$3.7218,296 shs$11.07 million03/27/2024$3.74$3.74$3.74$3.7218,296 shs$11.07 million03/26/2024$3.74$3.74$3.74$3.7218,296 shs$11.07 million03/25/2024$3.74$3.74$3.74$3.7218,237 shs$11.07 million03/22/2024$3.75$3.74-0.27%$3.74$3.706,250 shs$11.07 million03/21/2024$3.79$3.75-1.06%$3.79$3.7110,856 shs$11.10 million03/20/2024$3.74$3.79+1.34%$3.80$3.728,177 shs$11.22 million03/19/2024$3.77$3.74-0.80%$3.77$3.7114,270 shs$11.07 million03/18/2024$3.79$3.77-0.53%$3.80$3.7010,206 shs$11.16 million03/15/2024$3.75$3.79+1.07%$3.79$3.7516,388 shs$11.22 million03/14/2024$3.77$3.75-0.53%$3.77$3.735,986 shs$11.10 million03/13/2024$3.75$3.77+0.53%$3.77$3.7210,653 shs$11.16 millionCould this Tiny Biotech End Disease Forever? (Ad)Imagine a revolutionary treatment capable of editing out ANY disease. By literally "cutting" the genetic instructions that cause illness, and "pasting" in corrected DNA to restore perfect health.Access my full "Cut & Paste" profit analysis now.03/12/2024$3.78$3.75-0.79%$3.79$3.7517,808 shs$11.10 million03/11/2024$3.74$3.78+1.07%$3.79$3.7217,870 shs$11.19 million03/08/2024$3.74$3.74$3.75$3.718,709 shs$11.07 million03/07/2024$3.65$3.74+2.47%$3.75$3.687,273 shs$11.07 million03/06/2024$3.57$3.65+2.24%$3.72$3.55129,157 shs$10.80 million03/05/2024$3.65$3.57-2.19%$3.69$3.5614,661 shs$10.57 million03/04/2024$3.66$3.65-0.27%$3.73$3.6121,032 shs$10.80 million03/01/2024$3.62$3.66+1.10%$3.73$3.6110,577 shs$10.83 million02/29/2024$3.63$3.62-0.28%$3.70$3.6113,003 shs$10.72 million02/28/2024$3.65$3.63-0.55%$3.73$3.6225,675 shs$10.75 million02/27/2024$3.67$3.65-0.54%$3.73$3.658,961 shs$10.80 million02/26/2024$3.66$3.67+0.27%$3.69$3.6547,672 shs$10.86 million02/23/2024$3.67$3.66-0.27%$3.70$3.6637,047 shs$10.83 million02/22/2024$3.70$3.67-0.81%$3.70$3.644,388 shs$10.86 million02/21/2024$3.68$3.70+0.54%$3.72$3.664,606 shs$10.95 million02/20/2024$3.65$3.68+0.82%$3.75$3.6563,635 shs$10.89 million02/19/2024$3.65$3.65$3.70$3.6410,400 shs$10.80 million02/16/2024$3.70$3.65-1.35%$3.70$3.6410,447 shs$10.80 million02/15/2024$3.67$3.70+0.82%$3.73$3.6547,462 shs$10.95 million02/14/2024$3.69$3.67-0.54%$3.73$3.6728,885 shs$10.86 million02/13/2024$3.73$3.69-1.07%$3.72$3.6718,632 shs$10.92 million02/12/2024$3.73$3.73$3.73$3.709,964 shs$11.04 million02/09/2024$3.68$3.73+1.36%$3.75$3.6730,698 shs$11.04 million02/08/2024$3.74$3.68-1.60%$3.74$3.6816,666 shs$10.89 million02/07/2024$3.80$3.74-1.58%$3.86$3.68112,644 shs$11.07 million Related Companies: Western Asset Short Duration Income ETF Stock Chart First Trust RiverFront Dynamic Europe ETF Stock Chart Goldman Sachs ActiveBeta Europe Equity ETF Stock Chart Defiance S&P 500 Target Income ETF Stock Chart CP High Yield Trend ETF Stock Chart FT Raymond James Multicap Growth Equity ETF Stock Chart FlexShares Emerging Markets Quality Low Volatility Index Fund Stock Chart Global X MSCI Vietnam ETF Stock Chart CoreValues Alpha Greater China Growth ETF Stock Chart iShares USD Bond Factor ETF Stock Chart Receive NGE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Global X MSCI Nigeria ETF and its competitors with MarketBeat's FREE daily newsletter. This page (NYSEARCA:NGE) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm PressCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward PressThe #1 lithium battery stock to have on your radar in 2024!Smallcaps DailyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global X MSCI Nigeria ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.